Skip to main content

Advertisement

SpringerLink
Log in

CTNNB1-mutated melanocytic lesions with DPN like features: a distinct subtype of melanocytic tumors? A report of two cases

  • Brief Report
  • Published:
Virchows Archiv Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Demunter A et al (2002) Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations. Mod Pathol 15(4):454–461

    Article  PubMed  Google Scholar 

  2. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17(1):9–26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lazar AJ et al (2008) Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173(5):1518–1527

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Omholt K et al (2001) Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma. Int J Cancer 92(6):839–842

    Article  CAS  PubMed  Google Scholar 

  5. Pollock PM, Hayward N (2002) Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines. Melanoma Res 12(2):183–186

    Article  CAS  PubMed  Google Scholar 

  6. Reifenberger J et al (2002) Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. Int J Cancer 100(5):549–556

    Article  CAS  PubMed  Google Scholar 

  7. Gallagher SJ et al (2013) Beta-catenin inhibits melanocyte migration but induces melanoma metastasis. Oncogene 32(17):2230–2238

    Article  CAS  PubMed  Google Scholar 

  8. Rubinfeld B et al (1997) Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275(5307):1790–1792

    Article  CAS  PubMed  Google Scholar 

  9. van Engen-van Grunsven AC et al (2014) Update on molecular pathology of cutaneous melanocytic lesions: what is new in diagnosis and molecular testing for treatment? Front Med (Lausanne) 1:39

    Google Scholar 

  10. Blokx WA, van Dijk MC, Ruiter DJ (2010) Molecular cytogenetics of cutaneous melanocytic lesions—diagnostic, prognostic and therapeutic aspects. Histopathology 56(1):121–132

    Article  PubMed  Google Scholar 

  11. Yeh I et al (2017) Combined activation of MAP kinase pathway and beta-catenin signaling cause deep penetrating nevi. Nat Commun 8(1):644

    Article  PubMed  PubMed Central  Google Scholar 

  12. Eijkelenboom A et al (2016) Reliable next-generation sequencing of formalin-fixed, paraffin-embedded tissue using single molecule tags. J Mol Diagn 18(6):851–863

    Article  CAS  PubMed  Google Scholar 

  13. Luzar B, Calonje E (2011) Deep penetrating nevus: a review. Arch Pathol Lab Med 135(3):321–326

    PubMed  Google Scholar 

  14. Strazzula L et al (2014) The deep penetrating nevus. J Am Acad Dermatol 71(6):1234–1240

    Article  PubMed  Google Scholar 

  15. Robson A et al (2003) Deep penetrating naevus: clinicopathological study of 31 cases with further delineation of histological features allowing distinction from other pigmented benign melanocytic lesions and melanoma. Histopathology 43(6):529–537

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

There was no funding involved.

Author information

Authors and Affiliations

  1. Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands

    B. T. Teunissen, G. J. Knuiman, A. Eijkelenboom & W. A. M. Blokx

  2. Department of Pathology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands

    C. A. P. Wauters

  3. Department of Pathology, VieCuri Medical Center, Venlo, The Netherlands

    S. Wouda

Authors
  1. B. T. Teunissen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. J. Knuiman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Eijkelenboom
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. A. P. Wauters
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Wouda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. A. M. Blokx
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. J. Knuiman.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Both patients signed an informed consent form.

Electronic supplementary material

The datasets generated during this study are available in the “figshare” repository.

ESM 1

Figures of immunohistochemical staining (PPTX 96960 kb)

ESM 2

Description of the NGS gene panels (DOCX 14 kb)

ESM 3

Description of the firms, solutions and clones used with immunohistochemistry (DOCX 12 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teunissen, B.T., Knuiman, G.J., Eijkelenboom, A. et al. CTNNB1-mutated melanocytic lesions with DPN like features: a distinct subtype of melanocytic tumors? A report of two cases. Virchows Arch 472, 683–687 (2018). https://doi.org/10.1007/s00428-017-2250-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-017-2250-8

Search

Navigation